1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6586232C60504943A8525823B005798B7
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/improving-medical-affairs-booth-impact-at-congresses?opendocument
18
19opendocument
2054.198.246.164
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Medical Communication

Best Practices in Improving Medical Affairs Booth Impact at Congresses: Performance Measurement and Poster/Investigator Receptions

ID: 5500


Features:

14 Info Graphics

17 Data Graphics

200 Metrics

3 Narratives


Pages/Slides: 38


Published: 2018


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Best Practices in Improving Medical Affairs Booth Impact at Congresses: Performance Measurement and Poster/Investigator Receptions"


STUDY OVERVIEW


The medical communications staff charged with creating and managing booth exhibits are grappling with producing compelling and interactive medical information displays while balancing internal compliance requirements. It is in this evolving environment that communications staff are scrambling to keep up with current booth practices and the always challenging issue of measuring booth effectiveness.


Best Practices, LLC performed this research study to identify current booth practices such as gaming, poster/investigator receptions, and presenting US and EU content at international conferences. The study also examines booth performance measurement and how organizations are measuring the effectiveness of their medical booth presence.

This study will allow pharma leaders who oversee or are involved with medical booth displays at congresses to compare their booth practices and performance measurement approaches with peer organizations.

This study contains segments for Hematology/Oncology and Non-Hematology/Oncology as well as Large and Small Companies.


KEY TOPICS

  • Approaches to US and EU Content
  • Measuring Medical Booth Success
  • Poster/Investigator Events at Congresses

SAMPLE KEY METRICS

  • Are you permitted to send posters or other content to attendees by e-mail?
  • Do you utilize interactive educational games at your booth?
  • Does your company allow poster casts?
  • Do you have different content for US and EU information at international conferences?
  • Indicate the effectiveness of these metrics for measuring the value of your booth content
  • Does your company host poster/investigator receptions at congresses?
  • What type of content do you utilize at poster/investigator receptions at congresses?
  • What are your attendance restrictions for poster/investigator receptions?

SAMPLE KEY FINDINGS

  • HemOnc booths are more likely to use interactive educational games than Non-HemOnc booths.
  • Only a few companies in both segments are utilizing a poster cast featuring a presenting author with an audio accessed through a free iPhone app. A number of study participants, however, identified this as an attractive innovation.

METHODOLOGY

Best Practices, LLC engaged 21 Medical Affairs leaders at 20 pharmaceutical companies for this research project. In addition to utilizing a survey to collect quantitative data, the study included four executive interviews to collect qualitative data.


Industries Profiled:
Biotech; Pharmaceutical; Manufacturing; Chemical; Health Care; Biopharmaceutical; Clinical Research; Laboratories


Companies Profiled:
Allergan; amag; Amgen; AstraZeneca; Biogen; Boehringer Ingelheim; Celgene; Exelixis ; Ferring Pharmaceuticals; LifeScan; Indivior; Merck; Genentech; Novartis; Pfizer; Sanofi; Sunovion; TG Therapeutics; Tillotts Pharma; Takeda Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.